Liquid Biopsy Monitoring in BRAF-V600E Mutated NSCLC Patients Treated With Dabrafenib Plus Trametinib: A Prospective, Explorative, Multicentric Study. LiBRA_study (GOIRC-03-2020)
M. Pluchino,
R. Minari,
A. Leonetti,
F. Bonatti,
F. Passiglia,
A. Sartore-Bianchi,
D. Cortinovis,
L. Toschi,
F. Gelsomino,
S. Frega,
M. Tiseo
Affiliations
M. Pluchino
Medical Oncology Unit, University Hospital Of Parma, Parma, Italy
R. Minari
Medical Oncology Unit, University Hospital Of Parma, Parma, Italy; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy
A. Leonetti
Medical Oncology Unit, University Hospital Of Parma, Parma, Italy; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy
F. Bonatti
Medical Oncology Unit, University Hospital Of Parma, Parma, Italy
F. Passiglia
Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, TO, Italy
A. Sartore-Bianchi
S.C. Ricerca Clinica e Innovazione, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
D. Cortinovis
SC Oncologia medica Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
L. Toschi
Medical Oncology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy
F. Gelsomino
Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
S. Frega
Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy
M. Tiseo
Medical Oncology Unit, University Hospital Of Parma, Parma, Italy; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy
